| Patient | Michelangelo Buonarroti |
|---|---|
| Date of birth | 1475-03-06 |
| Identifiers | MRN HR-RE002-SYN-TD; SSN (made up) 000-02-7781 |
| Document date | 2026-11-01 |
| Author | Serena Castellano, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Primary care visit for painful, stiff hands that make writing, drawing, and carving difficult. Concerns: Aching, stiff hands, worst at the base of the left thumb, that make holding a chisel, a pen, or a brush hard; He will not stop carving and wants treatment that keeps him working. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Ibuprofen 200 mg oral tablet (over the counter), two tablets by mouth three times daily | Two tablets by mouth three times daily | Oral route | 1559-12-01 to 1560-03-16 | stopped | S |
| Allopurinol 100 mg oral tablet, two tablets (200 mg) by mouth daily | Two tablets by mouth daily | Oral route | 1552-06-04 | active | S |
| Diclofenac sodium 1% topical gel, 2 g to the painful hand joints four times daily, no more than 8 g a day to either hand | Apply 2 g to the affected hand joints four times daily | Topical route | 1560-03-16 | active | S |
| Acetaminophen 500 mg oral tablet, two tablets by mouth up to three times daily as needed for hand pain, no more than 3 g a day | Two tablets up to three times daily as needed; maximum 6 tablets a day | Oral route | 1560-03-16 | active | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Radiographs of both hands (posteroanterior, oblique, and lateral): left first carpometacarpal joint-space loss with osteophytes and subluxation (Eaton stage III); narrowing and osteophytes at the left thumb metacarpophalangeal and interphalangeal joints and the left index metacarpophalangeal and proximal interphalangeal joints; osteophytes at the right index and middle distal interphalangeal joints; no erosions, chondrocalcinosis, or hook-like osteophytes | 1560-03-16 to 1560-03-16 | completed | S |
| Thumb-base splint fitted: prefabricated hand-based first carpometacarpal orthosis for the left thumb, for heavy work and at night | 1560-03-16 to 1560-03-16 | completed | S |
| Injection of the left first carpometacarpal joint with triamcinolone acetonide 10 mg and 1% lidocaine under ultrasound guidance, by rheumatology | 1560-04-13 to 1560-04-13 | completed | S |
| Occupational hand therapy: four sessions of joint-protection teaching, thumb-stabilizing and range-of-motion exercises, and tool adaptation for carving and drawing | 1560-05-18 to 1560-06-15 | completed | S |
| Irrigation and simple repair of a 2.5 cm laceration of the dorsal left index finger over the proximal phalanx with four 5-0 nylon sutures under a digital block; extensor tendon intact on direct inspection | 1560-06-01 to 1560-06-01 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 1559-10-06 | High-dose influenza vaccine, 1559-1560 season | completed | S |
| 1556-10-17 | Pneumococcal conjugate vaccine PCV20 | completed | S |
| 1555-05-10 | Recombinant zoster vaccine, two-dose series completed | completed | S |
| 1548-04-07 | Tdap vaccine | completed | S |
| 1558-10-14 | Respiratory syncytial virus vaccine, single dose | completed | S |
| 1560-06-01 | Tdap vaccine for wound management, last dose more than 10 years ago | completed | S |
| 1560-09-14 | High-dose influenza vaccine, 1560-1561 season | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1544 to 1546 | Two acute illnesses, in the summer of 1544 and toward the close of 1545, with recovery; nature not recorded in the cited source | D (CLM-0015) |
| From about 1547 to 1553 | Hand deformities in his later portraits, proposed retrospectively to be osteoarthritis of the left thumb and index finger | R (CLM-0011) |
| 1548 | Dysuria | D (CLM-0004) |
| March to June 1549 | Urinary calculus with severe pain, treated with mineral water; passed fragments of the stone and improved; afterwards drank only spring water and changed his way of life | D (CLM-0005, CLM-0006, CLM-0007, CLM-0008) |
| June 16, 1557 | The stone, with difficulty passing water, and pains in the side and back that often kept him from stairs | D (CLM-0009) |
| June or July 1559 | Writing very troublesome to his hand, eyes, and memory | D (CLM-0010) |
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| father | Died in 1533 or 1534 at about ninety; cause not recorded in the cited source | D (CLM-0014) |
| Concern | Status | Evidence |
|---|---|---|
| Aching, stiff hands, worst at the base of the left thumb, that make holding a chisel, a pen, or a brush hard | active | S |
| He will not stop carving and wants treatment that keeps him working | active | S |
Most recent measures: Sodium [Moles/volume] in Serum or Plasma 140 on 1560-10-19; Potassium [Moles/volume] in Serum or Plasma 4.4 on 1560-10-19; Carbon dioxide, total [Moles/volume] in Serum or Plasma 25 on 1560-10-19; Urea nitrogen [Mass/volume] in Serum or Plasma 19 on 1560-10-19; Creatinine [Mass/volume] in Serum or Plasma 1 on 1560-10-19; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1555)/1.73 sq M 74 on 1560-10-19; Glucose [Mass/volume] in Serum or Plasma 94 on 1560-10-19; Urate [Mass/volume] in Serum or Plasma 5.2 on 1560-10-19; Hemoglobin [Mass/volume] in Blood 13.6 on 1560-03-16; Leukocytes [#/volume] in Blood by Automated count 6.2 on 1560-03-16; Platelets [#/volume] in Blood by Automated count 224 on 1560-03-16; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 17 on 1560-10-19; Calcium [Mass/volume] in Serum or Plasma 9.4 on 1560-03-16; 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma 34 on 1560-03-16; C reactive protein [Mass/volume] in Serum or Plasma 2.1 on 1560-03-16; Erythrocyte [Sedimentation Rate] in Blood 18 on 1560-03-16; Rheumatoid factor [Units/volume] in Serum or Plasma 8 on 1560-03-16; Cyclic citrullinated peptide Ab [Units/volume] in Serum 3 on 1560-03-16; Ferritin [Mass/volume] in Serum or Plasma 110 on 1560-03-16; Iron saturation [Mass Fraction] in Serum or Plasma 28 on 1560-03-16; Pain severity - 0-10 verbal numeric rating [Score] - Reported 3 on 1560-10-19; PROMIS upper extremity version 2.0 T-score 43 on 1560-10-19; Grip strength Hand - left Dynamometer 18 on 1560-10-19; Grip strength Hand - right Dynamometer 23 on 1560-10-19; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1560-09-14; Total score [Mini-Cog] 5 on 1560-09-14 [S]
Strengths and supports: Supports: devoted studio assistants, a nephew he writes to often, and a circle of friends [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Primary osteoarthritis of the left hand, worst at the thumb base (first carpometacarpal joint, Eaton stage III), with thumb metacarpophalangeal and interphalangeal and index metacarpophalangeal and proximal interphalangeal involvement; non-erosive | active | confirmed | M19.042 | S — Synthetic modern diagnosis confirmed by examination and radiographs. The joint pattern echoes the retrospective portrait-based interpretation (R, possible), which remains a hypothesis about the historical person; his documented difficulty writing is D. |
| Primary osteoarthritis of the right hand, mild, with Heberden nodes of the index and middle fingers | active | confirmed | M19.041 | S — Synthetic modern diagnosis; the portraits studied show only the left hand. |
| Chronic gout without tophi, in remission on allopurinol with serum urate at target | active | confirmed | M1A.9XX0 | S — Synthetic modern diagnosis, crystal-proven years ago in the synthetic history. Gout in the historical person is a retrospective reading of period language (R, possible). |
| History of urinary stones, passed spontaneously years ago; stone-free on fluids and allopurinol | active | confirmed | Z87.442 | S — Synthetic modern entry linked to the urinary calculus documented in his own letters (D); the composition of his historical stones is not known. |
| Laceration of the left index finger from a slipped chisel, 2.5 cm, without tendon, nerve, or nail injury; repaired and healed | resolved | confirmed | S61.211A | S — Synthetic injury at an unscheduled visit; weak pinch grip from thumb-base osteoarthritis let the chisel slip. It does not echo a documented injury. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1560-03-16 | Sodium [Moles/volume] in Serum or Plasma | 138 | mmol/L | 135-145 mmol/L | Normal | S |
| 1560-03-16 | Potassium [Moles/volume] in Serum or Plasma | 4.9 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1560-03-16 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 24 | mmol/L | 22-29 mmol/L | Normal | S |
| 1560-03-16 | Urea nitrogen [Mass/volume] in Serum or Plasma | 26 | mg/dL | 8-23 mg/dL | High | S |
| 1560-03-16 | Creatinine [Mass/volume] in Serum or Plasma | 1.21 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1560-03-16 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1555)/1.73 sq M | 59 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Low | S |
| 1560-03-16 | Glucose [Mass/volume] in Serum or Plasma | 92 | mg/dL | 70-99 mg/dL | Normal | S |
| 1560-03-16 | Urate [Mass/volume] in Serum or Plasma | 5.4 | mg/dL | 3.5-7.2 mg/dL | Normal | S |
| 1560-03-16 | Hemoglobin [Mass/volume] in Blood | 13.6 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 1560-03-16 | Leukocytes [#/volume] in Blood by Automated count | 6.2 | 10*3/uL | 3.4-9.6 10*3/uL | Normal | S |
| 1560-03-16 | Platelets [#/volume] in Blood by Automated count | 224 | 10*3/uL | 135-317 10*3/uL | Normal | S |
| 1560-03-16 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 18 | U/L | 7-55 U/L | Normal | S |
| 1560-03-16 | Calcium [Mass/volume] in Serum or Plasma | 9.4 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 1560-03-16 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 34 | ng/mL | 30-100 ng/mL | Normal | S |
| 1560-03-16 | C reactive protein [Mass/volume] in Serum or Plasma | 2.1 | mg/L | <=5 mg/L | Normal | S |
| 1560-03-16 | Erythrocyte [Sedimentation Rate] in Blood | 18 | mm/h | <=20 mm/h | Normal | S |
| 1560-03-16 | Rheumatoid factor [Units/volume] in Serum or Plasma | 8 | [IU]/mL | <=14 [IU]/mL | Normal | S |
| 1560-03-16 | Cyclic citrullinated peptide Ab [Units/volume] in Serum | 3 | U/mL | <=20 U/mL | Normal | S |
| 1560-03-16 | Ferritin [Mass/volume] in Serum or Plasma | 110 | ng/mL | 24-336 ng/mL | Normal | S |
| 1560-03-16 | Iron saturation [Mass Fraction] in Serum or Plasma | 28 | % | 20-50% | Normal | S |
| 1560-03-16 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 7 | {score} | S | ||
| 1560-03-16 | PROMIS upper extremity version 2.0 T-score | 33 | {T-score} | S | ||
| 1560-03-16 | Grip strength Hand - left Dynamometer | 14 | kg | S | ||
| 1560-03-16 | Grip strength Hand - right Dynamometer | 22 | kg | S | ||
| 1560-04-13 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 1560-04-13 | Potassium [Moles/volume] in Serum or Plasma | 4.5 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1560-04-13 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 25 | mmol/L | 22-29 mmol/L | Normal | S |
| 1560-04-13 | Urea nitrogen [Mass/volume] in Serum or Plasma | 20 | mg/dL | 8-23 mg/dL | Normal | S |
| 1560-04-13 | Creatinine [Mass/volume] in Serum or Plasma | 1.02 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1560-04-13 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1555)/1.73 sq M | 72 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1560-04-13 | Glucose [Mass/volume] in Serum or Plasma | 90 | mg/dL | 70-99 mg/dL | Normal | S |
| 1560-04-13 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 5 | {score} | S | ||
| 1560-04-13 | PROMIS upper extremity version 2.0 T-score | 37 | {T-score} | S | ||
| 1560-04-13 | Grip strength Hand - left Dynamometer | 15 | kg | S | ||
| 1560-04-13 | Grip strength Hand - right Dynamometer | 22 | kg | S | ||
| 1560-07-13 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 3 | {score} | S | ||
| 1560-07-13 | PROMIS upper extremity version 2.0 T-score | 42 | {T-score} | S | ||
| 1560-07-13 | Grip strength Hand - left Dynamometer | 17 | kg | S | ||
| 1560-07-13 | Grip strength Hand - right Dynamometer | 23 | kg | S | ||
| 1560-10-19 | Urate [Mass/volume] in Serum or Plasma | 5.2 | mg/dL | 3.5-7.2 mg/dL | Normal | S |
| 1560-10-19 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 1560-10-19 | Potassium [Moles/volume] in Serum or Plasma | 4.4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1560-10-19 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 25 | mmol/L | 22-29 mmol/L | Normal | S |
| 1560-10-19 | Urea nitrogen [Mass/volume] in Serum or Plasma | 19 | mg/dL | 8-23 mg/dL | Normal | S |
| 1560-10-19 | Creatinine [Mass/volume] in Serum or Plasma | 1 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1560-10-19 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1555)/1.73 sq M | 74 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1560-10-19 | Glucose [Mass/volume] in Serum or Plasma | 94 | mg/dL | 70-99 mg/dL | Normal | S |
| 1560-10-19 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 17 | U/L | 7-55 U/L | Normal | S |
| 1560-10-19 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 3 | {score} | S | ||
| 1560-10-19 | PROMIS upper extremity version 2.0 T-score | 43 | {T-score} | S | ||
| 1560-10-19 | Grip strength Hand - left Dynamometer | 18 | kg | S | ||
| 1560-10-19 | Grip strength Hand - right Dynamometer | 23 | kg | S | ||
| 1560-09-14 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 1560-09-14 | Total score [Mini-Cog] | 5 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1560-03-16 | Body height | 168 | cm | S |
| 1560-03-16 | Body weight | 62 | kg | S |
| 1560-03-16 | Body mass index (BMI) [Ratio] | 22 | kg/m2 | S |
| 1560-03-16 | Systolic blood pressure | 148 | mm[Hg] | S |
| 1560-03-16 | Diastolic blood pressure | 82 | mm[Hg] | S |
| 1560-03-16 | Heart rate | 72 | /min | S |
| 1560-03-16 | Respiratory rate | 16 | /min | S |
| 1560-03-16 | Body temperature | 36.6 | Cel | S |
| 1560-03-16 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1560-04-13 | Body height | 168 | cm | S |
| 1560-04-13 | Body weight | 61.8 | kg | S |
| 1560-04-13 | Body mass index (BMI) [Ratio] | 21.9 | kg/m2 | S |
| 1560-04-13 | Systolic blood pressure | 134 | mm[Hg] | S |
| 1560-04-13 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1560-04-13 | Heart rate | 70 | /min | S |
| 1560-04-13 | Respiratory rate | 16 | /min | S |
| 1560-04-13 | Body temperature | 36.7 | Cel | S |
| 1560-04-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1560-07-13 | Body height | 168 | cm | S |
| 1560-07-13 | Body weight | 61.4 | kg | S |
| 1560-07-13 | Body mass index (BMI) [Ratio] | 21.8 | kg/m2 | S |
| 1560-07-13 | Systolic blood pressure | 132 | mm[Hg] | S |
| 1560-07-13 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1560-07-13 | Heart rate | 68 | /min | S |
| 1560-07-13 | Respiratory rate | 16 | /min | S |
| 1560-07-13 | Body temperature | 36.6 | Cel | S |
| 1560-07-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1560-10-19 | Body height | 168 | cm | S |
| 1560-10-19 | Body weight | 61.6 | kg | S |
| 1560-10-19 | Body mass index (BMI) [Ratio] | 21.8 | kg/m2 | S |
| 1560-10-19 | Systolic blood pressure | 130 | mm[Hg] | S |
| 1560-10-19 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1560-10-19 | Heart rate | 70 | /min | S |
| 1560-10-19 | Respiratory rate | 16 | /min | S |
| 1560-10-19 | Body temperature | 36.6 | Cel | S |
| 1560-10-19 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1560-06-01 | Body height | 168 | cm | S |
| 1560-06-01 | Body weight | 61.6 | kg | S |
| 1560-06-01 | Body mass index (BMI) [Ratio] | 21.8 | kg/m2 | S |
| 1560-06-01 | Systolic blood pressure | 138 | mm[Hg] | S |
| 1560-06-01 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1560-06-01 | Heart rate | 80 | /min | S |
| 1560-06-01 | Respiratory rate | 16 | /min | S |
| 1560-06-01 | Body temperature | 36.7 | Cel | S |
| 1560-06-01 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1560-09-14 | Body height | 168 | cm | S |
| 1560-09-14 | Body weight | 61.2 | kg | S |
| 1560-09-14 | Body mass index (BMI) [Ratio] | 21.7 | kg/m2 | S |
| 1560-09-14 | Systolic blood pressure | 128 | mm[Hg] | S |
| 1560-09-14 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 1560-09-14 | Heart rate | 68 | /min | S |
| 1560-09-14 | Respiratory rate | 16 | /min | S |
| 1560-09-14 | Body temperature | 36.6 | Cel | S |
| 1560-09-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 1560-03-16 | Primary care visit for painful, stiff hands that make writing, drawing, and carving difficult | finished | S |
| 1560-04-13 | Four-week hand osteoarthritis review after stopping oral ibuprofen, with rheumatology consultation | finished | S |
| 1560-07-13 | Hand osteoarthritis review three months after a thumb-base injection | finished | S |
| 1560-10-19 | Hand osteoarthritis and gout review at about seven months | finished | S |
| 1560-06-01 | Same-day sick visit for a chisel cut to the left index finger | finished | S |
| 1560-09-14 | Subsequent annual wellness visit | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Hand exercise and joint protection: daily thumb-stabilizing and range-of-motion exercises, padded and thicker tool handles, a lighter mallet, and rest breaks during carving, taught in a course of occupational hand therapy | completed | GL-ACR-OA-2019, GL-CMID-2026 | S |
| Hand-based thumb splint for the left first carpometacarpal joint during heavy work and at night | completed | GL-ACR-OA-2019, GL-CMID-2026 | S |
| Stop over-the-counter ibuprofen; use topical diclofenac gel first and acetaminophen as needed up to 3 g a day; avoid regular oral NSAIDs at his age because of kidney, blood pressure, bleeding, and gout risks; recheck creatinine in four weeks | completed | GL-ACR-OA-2019, GL-CMID-2026, GL-AGS-BEERS-2023 | S |
| Rheumatology consultation to confirm hand osteoarthritis, exclude inflammatory and crystal arthritis, and advise on a thumb-base glucocorticoid injection and further options | completed | GL-ACR-OA-2019, GL-CMID-2026 | S |
| CMID osteoarthritis monitoring: pain rating, a validated function measure, grip strength, and joint examination at each visit; ALT when acetaminophen is used regularly; creatinine, blood count, and blood pressure if oral NSAIDs are ever used; no routine repeat radiographs; periodic mood and sleep screening | completed | GL-CMID-2026, GL-ACR-OA-2019 | S |
| Continue allopurinol 200 mg daily with serum urate every six months at target; drink at least 2 L of water a day to prevent stones | completed | GL-ACR-GOUT-2020, GL-AUA-STONE | S |
| Falls prevention: platform ladder with a rail, never climbing alone, good studio lighting, and a yearly fall-risk check | completed | GL-CMID-2026 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Hand pain at or below 3 of 10 on most days by the seven-month review | 1560-10-19 | completed | Pain 3 of 10, down from 7 | S |
| Carve for at least three hours a morning and write his own letters | 1560-10-19 | completed | Carving three to four hours most mornings; writes short letters with a thick-barrelled pen | S |
| No oral NSAID use and creatinine back to his baseline | 1560-04-13 | completed | Ibuprofen stopped; creatinine from 1.21 to 1.02 mg/dL | S |
| Serum urate below 6 mg/dL and no gout flare or stone | 1560-10-19 | completed | Urate 5.2 mg/dL; no flare or stone | S |
| No falls, with safe ladder and scaffold use | 1560-10-19 | active | No falls; he uses a platform ladder with a rail and does not climb alone | S |